###begin article-title 0
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Screening of common CYP1B1 mutations in Iranian POAG patients using a microarray-based PrASE protocol
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
The gene coding cytochrome P4501B1 (CYP1B1) has been shown to be a major cause of primary congenital glaucoma in the Iranian population. More recently it was shown to also be important in juvenile-onset open angle glaucoma (JOAG). We aimed to further investigate the role of CYP1B1 in a larger cohort of primary open angle glaucoma (POAG) patients which included late-onset patients. We also aimed to set up a microarray based protocol for mutation screening with an intent of using the protocol in a future population level screening program.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Sixty three POAG patients, nine affected family members, and thirty three previously genotyped primary congenital glaucoma (PCG) patients were included in the study. Clinical examination included slit lamp biomicroscopy, IOP measurement, gonioscopic evaluation, fundus examination, and measurement of perimetry. G61E, R368H, R390H, and R469W were screened by a protocol that included multiplexed allele specific amplification in the presence of a protease (PrASE), use of sequence tagged primers, and hybridization to generic arrays on microarray slides. The entire coding sequences of CYP1B1 and myocilin (MYOC) genes were sequenced in all individuals assessed by the microarray assay to carry a mutation. Intragenic single nucleotide polymorphism (SNP) haplotpes were determined for mutated alleles.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
Genotypes assessed by the array-based PrASE methodology were in 100% concordance with sequencing results. Seven mutation carrying POAG patients (11.1%) were identified, and their distribution was quite skewed between the juvenile-onset individuals (5/21) as compared to late-onset cases (2/42). Four of the seven mutation carrying Iranian patients harbored two mutated alleles. CYP1B1 mutated alleles in Iranian PCG and POAG patients shared common haplotypes. MYOC mutations were not observed in any of the patients.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
The PrASE approach allowed reliable simultaneous genotyping of many individuals. It can be an appropriate tool for screening common mutations in large sample sizes. The results suggest that CYP1B1 is implicated in POAG among Iranians, notably in the juvenile-onset form. Contrary to POAG patients studied in other populations, many mutation harboring Iranian patients carry two mutated alleles. We propose an explanation for this observation.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 869 870 869 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 240 246 <span type="species:ncbi:9606">people</span>
Glaucoma is a heterogeneous group of optic neuropathies which manifest by optic nerve head cupping or degeneration of the optic nerve, resulting in a specific pattern of visual field loss [1-3]. The disease affects approximately 65 million people worldwide and is considered the second leading cause of blindness [4]. It is sub-grouped into three major classes on the basis of etiology, anatomy of the anterior chamber, and age of onset [2]. Primary open angle glaucoma (POAG; OMIM ) accounts for 70% of glaucoma cases in Caucasian populations and usually affects individuals past the age of 40 [5]. In this form of glaucoma, the anterior chamber angle and the trabecular meshwork appear normal. POAG is sometimes divided into the two sub-classes of adult-onset (or late-onset) and juvenile-onset (JOAG), the latter appearing between early childhood and the age of 40 [6]. Primary congenital glaucoma (PCG; OMIM ) is characterized by an anatomic defect of the trabecualr meshwork (trabeculodysgenesis) and an age of onset in the neonatal or infantile period.
###end p 12
###begin p 13
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 465 471 465 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 587 593 587 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 707 713 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
Glaucoma in some families demonstrates Mendelian inheritance. Three POAG causing genes have been reported on the basis of genetic studies on multi-case families. The three genes code for myocilin (MYOC), optineurin (OPTN), and WD repeat containing protein 36 (WDR36) [6-8]. Mutations in MYOC were the cause of disease in less than 5 percent of POAG patients in various studies [8-10]. Mutations in OPTN and WDR36 have only rarely been found in POAG patients [7,8]. CYP1B1 (OMIM ), encoding cytochrome P4501B1, is a gene commonly associated with primary congenital glaucoma. Mutations in CYP1B1 account for the disease status of 20 to 100% of PCG patients in various populations [11]. Recently, mutations in CYP1B1 have been reported in POAG patients [12-16].
###end p 13
###begin p 14
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 645 651 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 551 559 <span type="species:ncbi:9606">patients</span>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
###xml 827 835 <span type="species:ncbi:9606">patients</span>
###xml 992 1000 <span type="species:ncbi:9606">patients</span>
The genetic basis of PCG among Iranian patients has been studied and it was found that nearly 70% of Iranian PCG patients carry disease associated mutations in CYP1B1 [17]. Although nineteen mutations were observed among the 104 patients studied, four (G61E, R368H, R390H, and R469W) constituted 76.2% of the mutated CYP1B1 alleles identified. More recently [13], it was observed that mutations in CYP1B1 accounted for disease status in four probands (17.4%) of a cohort of 23 unrelated Iranians affected with JOAG. The mutations observed in the JOAG patients were among the aforementioned common mutations. The relatively large contribution of CYP1B1 to glaucoma among Iranians suggested by the results of these studies prompted us to further investigate its role in a larger cohort of POAG patients which included late-onset patients. We chose to address only the common mutations with an intent of setting up a neonatal or population level screening protocol to be used in the future. The patients were screened for the mutations by a protocol which included a protease-mediated allele-specific primer extension (PrASE) reaction and hybridization to generic oligonucleotide tag sequences arrayed onto microarray chips [18]. Whereas various technologies have been developed to allow scoring of thousands of sequence variations, the PrASE/microarray protocol is designed for relatively small scale projects wherein far fewer variations are queried in many samples [19]. The results of our effort are presented.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 199 211 <span type="species:ncbi:9606">participants</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">patients</span>
###xml 760 768 <span type="species:ncbi:9606">patients</span>
###xml 806 814 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
###xml 1173 1181 <span type="species:ncbi:9606">patients</span>
###xml 1458 1466 <span type="species:ncbi:9606">patients</span>
This research was performed in accordance with the Helsinki Declaration and with the approval of the ethics board of the International Institute of Genetic Engineering and Biotechnology in Iran. The participants or authorized family members all consented to participate after being informed of the nature of the research. Sixty three unrelated POAG patients were recruited from the ophthalmology divisions of the Hazrat Rasool Hospital (associated with Iran University of Medical Sciences) and the Labbafinejad Hospital (associated with Shaheed Beheshti University of Medical Sciences) in Tehran. The hospitals are national reference centers, and patients from throughout Iran are referred to them. Nine additional affected individuals who were related to the patients were also included in the study. All patients were diagnosed to be affected by at least one of the authors (N.N. or S.Y.) who are glaucoma specialists. Clinical examination and criteria for diagnosis were as previously described [13]. None of the patients had phenotypic characteristics suggestive of PCG such as megalocornea, Descemet's membrane rupture (Haab's striae), corneal scarring, or edema. The patients were recruited consecutively without regard to familial status of disease. They were subsequently queried on the familial status of disease, and those who reported consanguinity between parents and/or incidence of disease among relatives were designated familial. None of the patients nor their family members were included in our previous studies.
###end p 16
###begin p 17
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 2589 2596 2589 2596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
The CYP1B1 mutations addressed by the microarray-based PrASE protocol were c.182G>A causing p.G61E, c.1103G>A causing p.R368H, c.1169G>A causing p.R390H, and c.1405C>T causing p.R469W (reference sequences:  and ). Polymerase chain reactions (PCR) and hybridization onto chips were done essentially as already described [18]. Briefly, a multiplex outer PCR reaction was performed on extracted DNA, and one microliter of this reaction was used as template for a multiplex nested PCR. Subsequently, the inner PCR amplicons served as template in a PrASE reaction in which extension of mismatched primers was made unlikely by inclusion of a protease that degrades the DNA polymerase. Two allele specific primers for each of the four mutation sites were present in the PrASE reaction, and each of the eight primers contained at its 5' end a unique sequence complementary to one of the tag oligonucleotides on a generic tag-array. Cy3 labeled dNTPs were also present which allowed fluorescence detection. The products of the PrASE reaction were hybridized to tag-spotted microarrays. Spotting was done using the VersArray ChipWriter (Bio-Rad, Milan, Italy). Each microarray slide was spotted with 48 arrays of 30 tag oligonucleotides in triplicate (array on array). Prior to hybridization, the arrays on each slide were placed into 48 compartments with a home-made silicon rubber mask, and each compartment was used to assess the genotypes of one individual at the four mutation sites. Eight of the tag oligonucleotides were devoted to the present analysis. Fluorescence binding to the spots was detected using VersArray ChipReader (Bio-Rad). Fluorescence signals were measured with the GenePix 5.0 (Medical Devices, Sunnyvale, CA) image analysis software and the allelic fraction (AF) for each individual at each mutation site was calculated. AF is defined as intensity from the normal allele divided by sum of intensities from both alleles. A cluster diagram for each site was created by plotting the AFs of all individuals at that site against the logarithm of the sum of both his signals at that site. If AF values of multiple individuals are well clustered into groups with values approaching zero, one, and an intermediate value, genotypes of individuals in those clusters can be designated, respectively, homozygous for mutant allele, homozygous for normal allele, and heterozygous. The genotype of each individual at each position was called on the basis of his position in the respective cluster diagram. The sequences of all primers used in the PCR and PrASE reactions are presented in Table 1.
###end p 17
###begin title 18
Primer sequences.
###end title 18
###begin p 19
* Common sequence at 5 -termini of inner PCR forward primers and the biotinylated form of the same sequence are italicized. The biotinylated primer was included in the inner PCR reaction to allow capture of PCR products onto strepavidin coated beads before the PrASE reaction. paragraph sign 5 -termini sequences of PrASE primers complementary to the tag sequences on the arrays are underlined.
###end p 19
###begin p 20
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 714 720 714 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
Coding exons 2 and 3 of CYP1B1 of all individuals called heterozygous or homozygous at any of the four mutation positions were sequenced by the di-deoxy terminator protocol as previously reported [13]. These exons were also sequenced in four randomly chosen patients without mutations. Sequencing was done to confirm the genotype calls, identify possible second mutations in the gene, and to ascertain intragenic SNP haplotypes associated with the mutant alleles [17]. Additionally, the three exons of MYOC were sequenced in all individuals carrying one or two CYP1B1 mutated alleles as already described [13]. This was done to identify patients who may have carried mutations in both genes [14,20,21]. Intragenic CYP1B1 and MYOC SNP haplotypes of patients carrying CYP1B1 mutated alleles were ascertained using the PHASE 2.0 software [22,23].
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 55 62 55 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 826 834 826 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
###xml 709 717 <span type="species:ncbi:9606">patients</span>
The clinical features of the patients are presented in Table 2. Average age at diagnosis of the patients was 50.3 years old. Age at diagnosis of 21 of the 63 pateints (33.3%) ranged between 6 years and 38 years (average 25.5 years), and these patients were classified as juvenile-onset POAG cases. The average age at diagnosis of the late-onset cases was 62.7 years old. As the patients were recruited without regard to age, a notable fraction, possibly one third, of Iranian POAG patients may have juvenile onset. The heredity status of glaucoma of six of the patients was unknown. Of the remaining 57 patients, 39 (68%) were familial and 18 (32%) were sporadic. The fraction of juvenile and late onset POAG patients who were familial was approximately equal. Two pedigrees in which inheritance was familial are presented in Figure 1.
###end p 22
###begin title 23
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Phenotypic features of POAG patients and genotypes of patients with identified mutations.
###end title 23
###begin p 24
###xml 71 79 <span type="species:ncbi:9606">patients</span>
All data pertain to probands. The asterisk denotes average figures for patients without identifeid mutations. The sharp (hash mark) indicates haplotpes defined by nucleotides at SNP positions IVS1-13, c.142, c.355, c.1294, c.1347 and c.1358 (NM_000104.2); H1: -CCGGTA-; H2: -TGTCCA-; H3: -CCGCCA-. The double dagger (double dagger) indicates haplotypes defined by nucleotides at SNP positions c.-83, c.227 and IVS2+35 (NM_000261); H1: -GGG-; H2: -GGA-. In the table M=male; F=female; J=juvenile-onset POAG; L=late-onset POAG; f=familial; s=sporadic.
###end p 24
###begin p 25
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 190 191 190 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 280 286 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Familial POAG pedigrees. Probands are indicated with arrows. A: Pedigree JG-M-4; the age at onset of the two affected siblings was 24 and 25 years. Both carried homozygous CYP1B1 mutations. B: Pedigree LG-R-213; the age at onset of the three affected individuals was 60-68 years. CYP1B1 mutations were not observed in the proband of this pedigree.
###end p 25
###begin p 26
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
In addition to the sixty three patients and nine affected relatives, thirty three PCG patients known by sequencing from our previous studies to carry the mutations in the heterozygous or homozygous states were included in the PrASE/microarray analysis to enable formation of stronger clusters [17]. Therefore, 420 genotypes (genotypes of 105 individuals at 4 variant nucleotide sites) were queried by the protocol. The clusters for the four mutations are presented in Figure 2. The three possible genotypes of all the mutations are well clustered, suggesting that genotype calls can be made with confidence. The genotypes of the individuals as ascertained in the clusters could in all cases have been called by visual inspection of the fluorescence intensities on the arrays. Hybridizations on replicate spots were almost identical. All heterozygous and homozygous mutant genotype calls, and absence of the mutations in four individuals were confirmed by sequencing.
###end p 26
###begin p 27
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 260 268 <span type="species:ncbi:9606">patients</span>
Results of microarray-based PrASE genotypings. Cluster diagrams of genotyping results of 105 individuals for four common CYP1B1 mutations are shown. Red squares: PCG patients whose genotypes were known because of previous direct sequencing. Blue squares: POAG patients whose genotypes were determined by the PrASE/hybridization reactions.
###end p 27
###begin p 28
###xml 138 145 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 563 569 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1176 1183 1176 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1383 1387 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1446 1452 1446 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1464 1468 1464 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1589 1596 1589 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 1599 1601 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
###xml 828 836 <span type="species:ncbi:9606">patients</span>
###xml 975 983 <span type="species:ncbi:9606">patients</span>
###xml 1136 1144 <span type="species:ncbi:9606">patients</span>
###xml 1295 1300 <span type="species:ncbi:9606">human</span>
###xml 1428 1436 <span type="species:ncbi:9606">patients</span>
###xml 1487 1495 <span type="species:ncbi:9606">patients</span>
We identified mutations in three of the four screened positions. These mutations were found in seven (11.1%) of the 63 patients screened (Table 2). R469W was not observed in any of the patients. One heterozygous carrier of R368H (JG-R-226) was observed to also carry an E229K mutated allele upon sequencing. This mutation has previously been reported to be associated with PCG and POAG [12,15-17,24]. No additional disease associated mutation was observed in the remaining patients by sequencing. Both alleles were mutated in four of the seven patients harboring CYP1B1 mutations, and only one allele was mutated in the remaining three. G61E, the most frequent mutated CYP1B1 allele among Iranian PCG patients, was also the most frequently observed mutation among the POAG patients. The JOAG affected sibling of two of the JOAG patients (JG-R-226 and JG-M-4) had the same genotype as the respective proband. The haplotypes associated with most mutations observed in the POAG patients, as defined by six intragenic single nucleotide polymorphisms (SNPs), were the same as previously found to be associated with the same mutations in PCG patients of Iran and other populations (Table 2) [17]. The only exception was the E229K allele identified by sequencing. Multiple origins for this mutation in human history have been suggested based on haplotype data [17,20]. A disease associated MYOC mutation was not observed in any of the patients carrying CYP1B1 mutations. MYOC haplotypes in the patients defined by three common intragenic SNPs were the same as previously observed among Iranians (Table 2) [13].
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
Although the microarray-based PrASE protocol has been previously introduced as a technology alternative to direct sequencing, this work represents its first implementation designed to address a biological question [18,19,25]. The genotypes called were reproducible and in 100% concordance with sequencing data. We believe it is an appropriate tool for screening common mutations in large sample sizes, for example to obtain epidemiological data on carrier frequencies or prevalence rates. Our protocol can easily be upgraded to simultaneously screen a larger number of mutations. Multiplexing the PrASE reaction for up to 75 SNPs has been reported [25,26]. The use of microarray slides spotted with generic tag oligonucleotides allows the flexibility of using the same slides for querying mutations in different genes.
###end p 30
###begin p 31
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 719 725 719 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 954 960 954 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1174 1180 1174 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
We surmise the CYP1B1 mutations common in Iranian PCG patients may be associated with disease status in 11.1% of the Iranian POAG patients in our cohort. Five of the patients who carried disease associated CYP1B1 mutations were among the 21 juvenile-onset (JOAG) subgroup, a proportion (23.8%) similar to the proportion we recently reported for an independent cohort of Iranian JOAG patients (17.4%) [13]. Two of the patients who carried disease associated CYP1B1 mutations were among the 42 of the late-onset group (4.8%). The difference in proportion of JOAG patients (9/44; including patients of reference 14) and late onset POAG patients (2/42) is statistically significant (p=0.03). A similar trend on the role of CYP1B1 in JOAG and late onset POAG is revealed upon analysis of data presented in two previous studies which included both juvenile and late-onset cases [12,16]. These observations suggest that in addition to the significant role that CYP1B1 has in PCG, it may also have roles in juvenile and late-onset POAG and that its role in JOAG may be more notable than its role in late-onset POAG. The haplotype analysis presented here show that identical mutated CYP1B1 alleles may be involved in the etiology of the various forms of glaucoma, suggesting that other genetic and/or environmental factors can affect the course of disease development.
###end p 31
###begin p 32
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1148 1154 1148 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1641 1643 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1644 1646 1644 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 1682 1688 1682 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
###xml 855 861 <span type="species:ncbi:9606">people</span>
###xml 962 969 <span type="species:ncbi:9606">patient</span>
###xml 1367 1375 <span type="species:ncbi:9606">patients</span>
###xml 1449 1456 <span type="species:ncbi:9606">patient</span>
###xml 1554 1562 <span type="species:ncbi:9606">patients</span>
In three studies on the role of CYP1B1 in POAG of patients from various populations excluding the studies on Iranian patients, 29 of 518 patients (5.6%) were reported to carry mutations in the gene [12,15,16]. Among the 29 patients, only three carried two mutated alleles. The results at first appearance seem to be in contrast to the findings on the Iranian population wherein eight of the eleven POAG patients with CYP1B1 mutations carried two mutated alleles [13 and present study]. However, it is possible that this discordance is due to the combined effects of difference in role of CYP1B1 mutations in juvenile-onset and late-onset POAG, and difference in proportions of these classes of patients in the populations. In fact, The , sponsored by the US National Library of Medicine, states that juvenile open angle glaucoma affects about 1 in 50,000 people, whereas open angle glaucoma affects about one percent of individuals past the age of 40 years. Our patient recruitment suggests that a notably higher proportion, possibly one third, of Iranian POAG cases may be juvenile-onset cases (see results). We suggest that harboring two mutated CYP1B1 alleles will most likely result in the PCG phenotype. If genetic background and/or environmental factors preclude this outcome, the POAG phenotype may arise, most likely the juvenile form. All eight Iranian POAG patients carrying two mutated alleles were juvenile-onset cases, whereas only one patient with a single mutated allele was juvenile onset. Similarly, age at diagnosis of two of the three patients in the other populations who carried two mutated alleles was 13 and 18 years [12,16]. Individuals carrying one mutated CYP1B1 allele may be asymptomatic or only mildly symptomatic. If they develop glaucoma, it is more likely that they develop late-onset POAG rather than the more severe congenital or even juvenile forms of glaucoma.
###end p 32
###begin p 33
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 964 966 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1023 1029 1023 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1077 1083 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1223 1229 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
In Western populations wherein consanguineous marriages are rare and in populations wherein CYP1B1 is a cause of PCG in a relatively low percent of patients, possibly indicating low frequency of CYP1B1 mutated alleles in those populations, individuals who carry two mutated alleles will be correspondingly few and most of these will develop PCG. It will be more likely to identify POAG patients with one rather than two mutated alleles in these populations. However, in a population like Iran wherein extensive inbreeding exists and wherein mutated CYP1B1 alleles may be frequent, there are expected to be a larger number of patients with two mutated CYP1B1 alleles who do not develop PCG and proceed to develop POAG at a later age. The heteorozygotes are likely to have milder symptoms and remain undiagnosed. These considerations may explain why autosomal recessive inheritance for JOAG and JOAG/PCG mixed pedigrees are often observed in the Iranian population [13]. They may also shed light on the pathogenic effects of CYP1B1 mutations. It will be of interest to learn the CYP1B1 genotypes and inheritance pattern of JOAG in other populations with high rates of consanguineous marriages and high frequencies of mutated CYP1B1 alleles.
###end p 33
###begin p 34
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
We conclude that CYP1B1 is important in the etiology of POAG, particularly the juvenile form, in the Iranian population. Incomplete penetrance for CYP1B1 mutations with regard to PCG has been well documented [27]. However the results of the present study suggest that long-term follow up of unaffected individuals with an affected genotype may result in diagnosis of juvenile or late onset POAG. As all forms of glaucoma are devastating diseases which may lead to blindness and have notable social and economic consequences, it is recommended that the gene be screened for mutations in individuals at risk, and that phenotypically affected and unaffected individuals carrying mutated alleles be kept under medical surveillance.
###end p 34
###begin title 35
Acknowledgments
###end title 35
###begin p 36
###xml 13 21 <span type="species:ncbi:9606">patients</span>
We thank the patients and family members for participating in the study. This research was funded by grant number 250 of the National Institute of Genetic Engineering and Biotechnology, and by a grant from the Ophthalmic Research Center of Shaheed Beheshti University of Medical Sciences.
###end p 36
###begin title 37
References
###end title 37
###begin article-title 38
Gene mapping for primary open angle glaucoma.
###end article-title 38
###begin article-title 39
Recent advances in molecular genetics of glaucoma.
###end article-title 39
###begin article-title 40
Recent advances in molecular genetics of glaucomas.
###end article-title 40
###begin article-title 41
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 41
###begin article-title 42
Identification of a gene that causes primary open angle glaucoma.
###end article-title 42
###begin article-title 43
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 43
###begin article-title 44
Adult-onset primary open angle glaucoma caused by mutations in optineurin.
###end article-title 44
###begin article-title 45
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing.
###end article-title 45
###begin article-title 46
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 46
###begin article-title 47
Geneticsa and biochemistry of primary congenital glaucoma.
###end article-title 47
###begin article-title 48
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Primary role of CYP1B1 in Indian juvenile-onset POAG patients.
###end article-title 48
###begin article-title 49
Contributions of MYOC and CYP1B1 mutations to JOAG.
###end article-title 49
###begin article-title 50
Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotypes in India.
###end article-title 50
###begin article-title 51
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Heterozygous CYP1B1 gene mutations in Spanish patients with primary open-angle glaucoma.
###end article-title 51
###begin article-title 52
###xml 27 35 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.
###end article-title 52
###begin article-title 53
###xml 63 71 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.
###end article-title 53
###begin article-title 54
Competitive enzymatic reaction to control allele-specific extensions.
###end article-title 54
###begin article-title 55
Comparison of PrASE and Pyrosequencing for SNP Genotyping.
###end article-title 55
###begin article-title 56
Myocilin gene implicated in primary congenital glaucoma.
###end article-title 56
###begin article-title 57
Digenic inheritance of early-onset glaucoma: Cyp1b1, a potential modifier gene.
###end article-title 57
###begin article-title 58
A comparision of Bayesian methods for haplotype reconstruction from population genotype data.
###end article-title 58
###begin article-title 59
A new statistical method for haplotype reconstruction from population genotype data.
###end article-title 59
###begin article-title 60
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.
###end article-title 60
###begin article-title 61
Detection of MC1R Polymorphisms with Protease-Mediated Allele-Specific Extension as an Alternative to Direct Sequencing.
###end article-title 61
###begin article-title 62
Tri-nucleotide threading for parallel amplification of minute amounts of genomic DNA.
###end article-title 62
###begin article-title 63
Multiple CYP1B1 mutations and incomplete penetrance in inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.
###end article-title 63

